tiprankstipranks
Trending News
More News >
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
US Market

Jazz Pharmaceuticals (JAZZ) Income Statement

Compare
1,874 Followers

Jazz Pharmaceuticals Income Statement

Last quarter (Q4 2025), Jazz Pharmaceuticals's total revenue was $1.20B, an increase of 10.09% from the same quarter last year. In Q4, Jazz Pharmaceuticals's net income was $203.45M. See Jazz Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 4.27B$ 4.07B$ 3.83B$ 3.66B$ 3.09B
Gross Profit
$ 3.76B$ 3.62B$ 3.40B$ 3.12B$ 2.65B
Operating Expenses
$ 3.54B$ 2.91B$ 2.82B$ 3.18B$ 2.48B
Depreciation and Amortization
$ 542.00M$ 660.07M$ 638.70M$ 629.47M$ 552.48M
EBITDA
$ 108.46M$ 1.52B$ 1.45B$ 1.47B$ 1.03B
Operating Income
$ 224.42M$ 716.63M$ 578.58M$ -65.53M$ 170.28M
Other Income/Expenses
$ -853.01M$ -247.94M$ -283.66M$ -317.18M$ -283.83M
Pretax Income
$ -628.59M$ 468.69M$ 294.92M$ -382.70M$ -113.55M
Net Income
$ -356.15M$ 560.12M$ 414.83M$ -224.06M$ -328.95M
Per Share Metrics
Basic EPS
$ -5.84$ 9.06$ 6.55$ -3.58$ -5.51
Diluted EPS
$ -5.84$ 8.65$ 6.10$ -3.58$ -5.51
Weighted Average Shares Outstanding
60.98M 61.84M 63.29M 62.54M 59.69M
Weighted Average Shares Outstanding (Diluted)
60.98M 66.01M 72.07M 62.54M 59.69M
Currency in USD

Jazz Pharmaceuticals Earnings and Revenue History